{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:17:51Z","timestamp":1774340271930,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jacl.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T14:30:31Z","timestamp":1496413831000},"page":"1065-1072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol &lt;70\u00a0mg\/dL compared with a novel low-density lipoprotein estimation method"],"prefix":"10.1016","volume":"11","author":[{"given":"Seamus P.","family":"Whelton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Meeusen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie J.","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Saenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori J.","family":"Sokoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jacl.2017.05.005_bib1","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jacl.2017.05.005_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjcard.2015.05.013","article-title":"Reliability of calculated low-density lipoprotein cholesterol","volume":"116","author":"Meeusen","year":"2015","journal-title":"Am J Cardiol"},{"issue":"25 Suppl 2","key":"10.1016\/j.jacl.2017.05.005_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force\u00a0on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacl.2017.05.005_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cjca.2012.11.032","article-title":"2012 update of the\u00a0Canadian Cardiovascular Society guidelines for the diagnosis\u00a0and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"29","author":"Anderson","year":"2013","journal-title":"Can J Cardiol"},{"issue":"14","key":"10.1016\/j.jacl.2017.05.005_bib5","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"issue":"6 Suppl","key":"10.1016\/j.jacl.2017.05.005_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2017.05.005_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ahj.2014.07.028","article-title":"Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial","volume":"168","author":"Schwartz","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacl.2017.05.005_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2015.11.015","article-title":"Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with elevated risk trial","volume":"173","author":"Sabatine","year":"2016","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.jacl.2017.05.005_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.jacl.2017.05.005_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jacc.2016.03.519","volume":"68","author":"Lloyd-Jones","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2017.05.005_bib11","article-title":"Comparing Friedewald & novel calculations for estimating low-density lipoprotein cholesterol goal attainment using national health and nutrition examination survey data: implications for patient care","author":"Toth","year":"2016","journal-title":"ESC Congress"},{"issue":"10","key":"10.1016\/j.jacl.2017.05.005_bib12","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.108.777334","article-title":"Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events","volume":"118","author":"Mora","year":"2008","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.jacl.2017.05.005_bib13","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archinternmed.2012.3708","article-title":"Fasting time and lipid levels in a community-based population: a cross-sectional study","volume":"172","author":"Sidhu","year":"2012","journal-title":"Arch Intern Med"},{"issue":"22","key":"10.1016\/j.jacl.2017.05.005_bib14","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/jamainternmed.2013.1771","article-title":"Should we fast before we measure our lipids?","volume":"172","author":"Gaziano","year":"2012","journal-title":"Arch Intern Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417303318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417303318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T09:27:22Z","timestamp":1602235642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287417303318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1933287417303318"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2017.05.005","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70\u00a0mg\/dL compared with a novel low-density lipoprotein estimation method","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}